Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-11-30FDA Approved: CITALOPRAM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's generic citalopram under an original generic application (ANDA 077289).
-
FDA approval · 2006-11-17FDA Approved: FLUOXETINE — Supplemental Application (TIME CAP LABORATORIES, INC.)
The FDA approved a supplemental application for a fluoxetine hydrochloride product from Time Cap Laboratories, Inc., approving this generic …
-
CLINICAL_TRIALS trial_result · 2006-10-27Clinical Trial Update: Study of Whether Educational Visits to Primary Care Professionals Improves the Quality of Care They Provide. [NA]
A completed study evaluated whether educational visits to primary care professionals improve the quality of care they provide to patients wi…
-
FDA label_change · 2006-10-20FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC, likely involving labeling changes.
-
CLINICAL_TRIALS research · 2006-10-12Clinical Trial Update: A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care [Phase 1]
Phase 1 clinical trial evaluating a strategy to improve detection and management of suicide risk among depressed patients in primary care.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-10-09Clinical Trial Update: Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder [Phase 2]
Phase 2 trial suggests that a sedating antidepressant improves driving safety in adults with major depressive disorder.
-
FDA approval · 2006-10-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Bupropion Hydrochloride generic product by BluePoint Laboratories under an ANDA, updating the ap…
-
FDA approval · 2006-10-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York's supplemental application for a generic form of bupropion hydrochloride, authorizing it…
-
FDA approval · 2006-10-03FDA Approved: CITALOPRAM — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s original application for Citalopram, granting permission to market a generic version of the antidepressant.
-
CLINICAL_TRIALS research · 2006-09-29Clinical Trial Update: Healthy Outcomes of Pregnancy Education [Phase 2]
Phase 2 clinical trial update of a pregnancy education program sponsored by NICHD, focusing on environmental tobacco smoke exposure, depress…
-
CLINICAL_TRIALS trial_result · 2006-09-22Clinical Trial Update: The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD [Phase 2]
This update reports Phase 2 trial results for CP-101,606, an NMDA receptor antagonist, in patients with major depressive disorder.
-
FDA label_change · 2006-09-20FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company, approving changes to the …
-
FDA approval · 2006-09-20FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.
-
CLINICAL_TRIALS withdrawal · 2006-09-19Clinical Trial Update: Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents [Phase 3]
Phase 3 discontinuation study of citalopram in depressed adolescents has been withdrawn.
-
FDA approval · 2006-09-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2006-09-14Clinical Trial Update: The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis [Phase 4]
Phase 4 trial update on escitalopram for depression in multiple sclerosis has been terminated, with no further efficacy or safety results re…
-
CLINICAL_TRIALS trial_result · 2006-09-13Clinical Trial Update: A Study of Omega-3 as a Treatment for Major Depression [Phase 2]
Phase 2 clinical trial evaluating omega-3 fatty acids as a treatment for major depressive disorder and persistent depressive disorder; curre…
-
CLINICAL_TRIALS research · 2006-09-13Clinical Trial Update: A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression [Phase 2]
A Phase 2 clinical trial is evaluating omega-3 fatty acids as an augmentation to antidepressant treatment for major depressive disorder; the…
-
CLINICAL_TRIALS trial_result · 2006-09-12Clinical Trial Update: Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women [Phase 4]
This document summarizes the completion of a Phase 4 clinical trial evaluating sildenafil for SSRI-induced sexual dysfunction in women. The …
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Testosterone and Major Depression
Completed clinical trial at University Health Network evaluating testosterone for major depressive disorder.
-
CLINICAL_TRIALS research · 2006-09-08Clinical Trial Update: Evaluation of a MCYI as Adjunct to Psychiatric Treatment for Vietnam Veterans With PTSD - RCT [Phase 1]
An update on a Phase 1 randomized controlled trial evaluating MCYI as an adjunct to psychiatric treatment for Vietnam veterans with posttrau…
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid Recipients [NA]
This completed study evaluated the cost-effectiveness of generalist care managers in delivering depression treatment to Medicaid recipients …
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism. [Phase 4]
Phase 4 trial evaluating memantine hydrochloride in combination with escitalopram for co-morbid depression and alcoholism has completed.
-
FDA approval · 2006-08-28FDA Approved: CITALOPRAM HYDROBROMIDE — Original Application (Aurobindo Pharma Limited)
FDA approves the original application for a generic form of citalopram hydrobromide, manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2006-08-22FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.